Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy

Long-term uninterrupted therapy is essential for maximizing clinical benefits of antiangiogenic drugs (AADs) in cancer patients. Unfortunately, nearly all clinically available AADs are delivered to cancer patients using disrupted regimens. We aim to develop lifetime, nontoxic, effective, orally acti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Proc Natl Acad Sci U S A
Autors principals: Zhang, Yin, Sun, Meili, Huang, Guichun, Yin, Linlin, Lai, Qinghua, Yang, Yunlong, Xing, Xiaoming, Yu, Guohua, Sun, Yuping, Wang, Xinsheng, Nie, Guohui, Liu, Yizhi, Cao, Yihai
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2017
Matèries:
PNAS Plus
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5495268/
https://ncbi.nlm.nih.gov/pubmed/28607065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1705066114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars